| Citation: |
YANG Xingdong, YU Muyang, XU Yiming, ZHU Wei, HU Mingwei, WENG Xisheng, FENG Bin. Early Postoperative Safety of Total Hip Arthroplasty in Systemic Lupus Erythematosus Patients[J]. Medical Journal of Peking Union Medical College Hospital, 2025, 16(1): 42-49. DOI: 10.12290/xhyxzz.2024-0856
|
To analyze the occurrence of early complications after total hip arthroplasty (THA) in patients with systemic lupus erythematosus (SLE).
The data of patients who underwent THA at Peking Union Medical College Hospital from June 2012 to April 2024 were retrospectively and consecutively collected. The patients were categorized into SLE group and control group based on the presence or absence of SLE. Using propensity score matching, we matched patients in the two groups at a 1∶1 ratio according to gender, age, and surgical side. Subsequently, we compared the clinical characteristics, incidence of major complications within 30 days postoperatively, and allogeneic blood transfusion rates between the two groups.
A total of 270 patients in the SLE group who met the inclusion and exclusion criteria were selected. Within 30 days postoperatively, 18 cases (6.67%) experienced major complications, including 2 cases (0.74%) of upper respiratory tract infection, 2 cases (0.74%) of pulmonary infection, 3 cases (1.11%) of urinary tract infection, 2 cases (0.74%) of other systemic infection, 5 cases (1.85%) of poor wound healing, 1 case (0.37%) of wound infection, 1 case (0.37%) of gastrointestinal complications, 1 cases (0.37%) of shock, and 1 case (0.37%) of SLE flare-up. The allogeneic blood transfusion rate was 22.59% (61/270). After propensity score matching, 163 cases from SLE and control groups were included for analysis. (1) Regarding medical complications, compared with control group, SLE group showed significant differences in osteoporosis, respiratory system disorders, gastrointestinal diseases, urinary system disorders, hematologic abnormalities, and secondary or concomitant rheumatic diseases (all P < 0.05). (2) In terms of preoperative laboratory tests, SLE group had lower platelet counts, absolute lymphocyte counts, hemoglobin levels, hematocrit, albumin levels, blood glucose levels, and activated partial thromboplastin times than control group, while C-reactive protein, erythrocyte sedimentation rate, and D-dimer levels were higher (all P < 0.05). (3) Regarding surgical-related indicators, a higher proportion of patients in SLE group had an ASA grade > 2 (15.95% vs. 3.07%, P < 0.001), but intraoperative blood loss was significantly smaller [324.7 (200.0, 500.0) mL vs. 421.8 (200.0, 500.0) mL, P=0.005]. (4) In terms of complications, SLE group exhibited a significantly higher incidence of major complications than control group (8.59% vs. 1.23%, P=0.005), with a relative risk of 1.081 (95% CI: 1.028-1.136). No significant difference was observed in the allogeneic blood transfusion rate between SLE group and control group (25.77% vs. 17.18%, P=0.059).
The incidence of major complications within 30 days following THA in patients with SLE was significantly higher than that in non-SLE patients, while the rate of allogeneic blood transfusion remained comparable. To ensure the safety of THA surgery for patients with SLE, it is important to optimize the patient's condition and achieve stabilization prior to surgery. Additionally, strict perioperative management must be forced.
| [1] |
Cai Y R, Ding Z C, Rong X, et al. Does systemic lupus erythematosus increase the risk of complications from total hip arthroplasty?[J]. BMC Musculoskelet Disord, 2021, 22(1): 457. DOI: 10.1186/s12891-021-04316-3
|
| [2] |
Viswanathan V K, Sakthivelnathan V, Menedal A, et al. How does systemic lupus erythematosus impact the peri-operative complication rates in primary hip arthroplasty? A national inpatient sample-based study[J]. Arch Orthop Trauma Surg, 2023, 143(4): 2209-2216.
|
| [3] |
Kasturi S, Goodman S. Current perspectives on arthroplasty in systemic lupus erythematosus: rates, outcomes, and adverse events[J]. Curr Rheumatol Rep, 2016, 18(9): 59. DOI: 10.1007/s11926-016-0608-6
|
| [4] |
Chen C H, Chen T H, Lin Y S, et al. The impact of systemic lupus erythematosus on the risk of infection after total hip arthroplasty: a nationwide population-based matched cohort study[J]. Arthritis Res Ther, 2020, 22(1): 214. DOI: 10.1186/s13075-020-02300-1
|
| [5] |
Gu J M, Zhang S H, Chen L, et al. Performing a safe and effective total hip arthroplasty on patients with inactive or stably active systemic lupus erythematosus with osteonecrosis[J]. J Am Acad Orthop Surg, 2021, 29(10): 423-432. DOI: 10.5435/JAAOS-D-20-00464
|
| [6] |
Merayo-Chalico J, Gónzalez-Contreras M, Ortíz-Hernández R, et al. Total hip arthroplasty outcomes: an 18-year experience in a single center: is systemic lupus erythematosus a potential risk factor for adverse outcomes?[J]. J Arthroplasty, 2017, 32(11): 3462-3467. DOI: 10.1016/j.arth.2017.06.021
|
| [7] |
Mertelsmann-Voss C, Lyman S, Pan T J, et al. Arthroplasty rates are increased among US patients with systemic lupus erythematosus: 1991—2005[J]. J Rheumatol, 2014, 41(5): 867-874. DOI: 10.3899/jrheum.130617
|
| [8] |
Chen D Q, Cancienne J M, Werner B C, et al. Is osteonecrosis due to systemic lupus erythematosus associated with increased risk of complications following total hip arthroplasty?[J]. Int Orthop, 2018, 42(7): 1485-1490. DOI: 10.1007/s00264-018-3871-5
|
| [9] |
Goodman S M, Springer B D, Chen A F, et al. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons guideline for the perioperative manage-ment of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty[J]. Arthritis Care Res (Hoboken), 2022, 74(9): 1399-1408. DOI: 10.1002/acr.24893
|
| [10] |
Belmont P J, Goodman G P, Hamilton W, et al. Morbidity and mortality in the thirty-day period following total hip arthroplasty: risk factors and incidence[J]. J Arthroplasty, 2014, 29(10): 2025-2030. DOI: 10.1016/j.arth.2014.05.015
|
| [11] |
Kang Y, Zhang Z J, Zhao X Y, et al. Total hip arthroplasty for vascular necrosis of the femoral head in patients with systemic lupus erythematosus: a midterm follow-up study of 28 hips in 24 patients[J]. Eur J Orthop Surg Traumatol, 2013, 23(1): 73-79. DOI: 10.1007/s00590-012-0939-6
|
| [12] |
Kurtz S, Ong K, Lau E, et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030[J]. J Bone Joint Surg Am, 2007, 89(4): 780-785. DOI: 10.2106/00004623-200704000-00012
|
| [13] |
Schnaser E A, Browne J A, Padgett D E, et al. Periopera-tive complications in patients with inflammatory arthropathy undergoing total hip arthroplasty[J]. J Arthroplasty, 2016, 31(10): 2286-2290. DOI: 10.1016/j.arth.2016.03.023
|
| [14] |
Chen D Y, Xie J Y, Chen H H, et al. Infection in southern Chinese patients with systemic lupus erythematosus: spectrum, drug resistance, outcomes, and risk factors[J]. J Rheumatol, 2016, 43(9): 1650-1656. DOI: 10.3899/jrheum.151523
|
| [15] |
Johnson D J, Hartwell M J, Weiner J A, et al. Which postoperative day after total joint arthroplasty are catastrophic events most likely to occur?[J]. J Arthroplasty, 2019, 34(10): 2466-2472. DOI: 10.1016/j.arth.2019.05.033
|
| [16] |
Sodhi N, Anis H K, Coste M, et al. Thirty-day complica-tions in osteonecrosis patients following total hip arthroplasty[J]. J Arthroplasty, 2020, 35(8): 2136-2143. DOI: 10.1016/j.arth.2020.02.067
|
| [17] |
Anderson C G, Jang S J, Brilliant Z R, et al. Complication rate after primary total hip arthroplasty using the posterior approach and enabling technology: a consecutive series of 2, 888 hips[J]. J Arthroplasty, 2023, 38(S7): S119-S123.e3.
|
| [18] |
Issa K, Naziri Q, Rasquinha V J, et al. Outcomes of primary total hip arthroplasty in systemic lupus erythematosus with a proximally-coated cementless stem[J]. J Arthroplasty, 2013, 28(9): 1663-1666. DOI: 10.1016/j.arth.2013.02.024
|
| [19] |
Salt E, Wiggins A T, Rayens M K, et al. Moderating effects of immunosuppressive medications and risk factors for post-operative joint infection following total joint arthroplasty in patients with rheumatoid arthritis or osteoarthritis[J]. Semin Arthritis Rheum, 2017, 46(4): 423-429. DOI: 10.1016/j.semarthrit.2016.08.011
|
| [20] |
Li Z, Du Y, Xiang S, et al. Risk factors of perioperative complications and transfusion following total hip arthroplasty in systemic lupus erythematosus patients[J]. Lupus, 2019, 28(9): 1134-1140. DOI: 10.1177/0961203319862609
|
| [21] |
Meyerhoff J, Dorsch C A. Decreased platelet serotonin levels in systemic lupus erythematosus[J]. Arthritis Rheum, 1981, 24(12): 1495-1500. DOI: 10.1002/art.1780241207
|
| [1] | CHANG Guojing, XIA Zenan, ZHANG Xinran, KANG Yuanbo, ZHANG Hailin, LONG Xiao, ZHU Lin. Postoperative Complications of Minimally Invasive Vaginal Contraction: A Report of Six Cases[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(6): 1468-1474. DOI: 10.12290/xhyxzz.2024-0616 |
| [2] | LI Tianyu, ZHAO Bangbo, LI Zeru, ZHAO Yutong, HAN Xianlin, ZHANG Taiping, DAI Menghua, GUO Junchao, WANG Weibin. Surgical Efficacy and Quality of Life of Total Pancreatectomy versus Pancreatico- duodenectomy for Pancreatic Cancer: A Retrospective Cohort Study Based on Propensity Score Matching[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(4): 807-818. DOI: 10.12290/xhyxzz.2024-0163 |
| [3] | CHEN Bo, XU Yimin, PENG Huiming, FENG Bin, LIU Guanmo, WANG Xueqing, WENG Xisheng. Comparison of the Risk of Perioperative Blood Loss in Hemophilic Arthritis and Initial Total Hip Arthroplasty for Femoral Head Necrosis under Multimodal Blood Management Measures: A Retrospective Cohort Study[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(4): 814-819. DOI: 10.12290/xhyxzz.2023-0009 |
| [4] | CHANG Guojing, YU Nanze, LONG Xiao, WANG Xiaojun. Medical Aesthetic Surgery and Related Complications[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(3): 377-382. DOI: 10.12290/xhyxzz.2022-0056 |
| [5] | TENG Chu-bei, LI Xue-jun. Surgical Treatment for Craniovertebral Junction Malformations and Prevention of Complications[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(6): 727-731. DOI: 10.3969/j.issn.1674-9081.2020.06.016 |
| [6] | Yuan XIA, Xiang-pei LI. The Role of MicroRNA Regulation of Interferon-α in the Pathogenesis of Systemic Lupus Erythematosus[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(6): 673-678. DOI: 10.3969/j.issn.1674-9081.2019.06.021 |
| [7] | Fei WANG, Xue-fei DING, Yao-zong XU, Cheng-hao GUO, Liang-yong ZHU, Jia-nan XU, Yu-quan ZHOU, Yang LUAN, Sheng-ming LU, Tian-bao HUANG. Complications of Transperineal Template-guided Prostate Saturation Biopsy[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(4): 347-352. DOI: 10.3969/j.issn.1674-9081.2019.04.007 |
| [8] | Wei-bin WANG, Xiao-dong HE. Attach Importance to the Occurrence and Prevention of Surgical Complications[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(4): 313-316. DOI: 10.3969/j.issn.1674-9081.2019.04.001 |
| [9] | De-lin LIU, Wei-dong XU, Chen ZHANG, Ge ZHU, Xuan HUANG, Jia LI. Total Hip Arthroplasty for Ankylosing Spondylitis Involving Hip Joint[J]. Medical Journal of Peking Union Medical College Hospital, 2017, 8(4-5): 251-257. DOI: 10.3969/j.issn.1674-9081.2017.05.011 |
Supported by: Beijing Renhe Information Technology Co., Ltd. 
Submit
Review
Office
Email Alert
RSS
DownLoad: